Tacrolimus monotherapy in liver transplantation one-year results of a prospective, randomized, double-blind, placebo-controlled study

Annals of Surgery

Volumn 248, Issue 6, 2008, Pages 956-966

  Lerut, Jan ^a   Mathys, Jules ^a   Verbaandert, Catherine ^a   Talpe, Stéphanie ^a   Ciccarelli, Olga ^a   Lemaire, Julien ^a   Bonaccorsi Riani, Eliano ^a   Vanthuyne, Vincent ^a   Hetsch, Nathalie ^a   Roggen, Francine ^a   Reyck, Chantal D E ^a   Goffette, Pierre ^a   Latinne, Dominique ^a   Orlando, Giuseppe ^a   Rahier, Jacques ^a   Sempoux, Christine ^a   Wallemacq, Pierre ^a   Laterre, Pierre François ^a   Gianello, Pierre ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AZATHIOPRINE; CEPHALOSPORINASE; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; OXACILLIN; PLACEBO; POLYMYXIN; RAPAMYCIN; STEROID; TACROLIMUS; TEMOCILLIN; TOBRAMYCIN; VANCOMYCIN; IMMUNOSUPPRESSIVE AGENT;

ADD ON THERAPY; ADULT; AGED; ARTICLE; ARTIFICIAL ORGAN; BACTERIAL INFECTION; BILE DUCT DISEASE; BLINDNESS; BONE NECROSIS; CHRONIC GRAFT REJECTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; EPILEPSY; EYE DISEASE; FEMALE; FOLLOW UP; FRACTURE; GRAFT INFECTION; GRAFT NECROSIS; GRAFT SURVIVAL; HERPES SIMPLEX; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; LIVER FAILURE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; PAIN; POPULATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTOZOAL INFECTION; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SKIN DISEASE; SURVIVAL RATE; SURVIVOR; THROMBOSIS; IMMUNOLOGY; INTRAHEPATIC CHOLESTASIS; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME;

ADULT; AGED; CHOLESTASIS, INTRAHEPATIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 57349098355     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31819009c9     Document Type: Article

References (55)

1. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361:1502-1510.
2. Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol. 2001;1:233-239.
3. Wang C, Sun J, Sheil AGR, et al. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation. 2001;72:44-51.
4. Qian S, Thai NL, Lu L, et al. Liver transplant tolerance: mechanistic insights from animal models, with particular reference to the mouse. Transplant Rev. 1997;11:151-164.
5. Starzl TE, Demetris AJ. Liver Transplantation. Chicago, IL; 1990.
6. Reding R. Steroid withdrawal in liver transplantation: benefits, risks and unanswered questions. Transplantation. 2000;70:405-410.
7. Kasiske BL, Chakkera HA, Louis TA, et al. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. JAmSoc Nephrol. 2000;11:1910-1917.
8. Lerut J. Avoiding steroids in solid organ transplantation. Transpl Int. 2003;16:213-224.
9. Lerut J, Ciccarelli O, Roggen F, et al. Cavo-caval adult liver transplantation and retransplantation without veno-venous bypass and without porta-caval shunting: a prospective feasibility study in adult liver transplantation. Transplantation. 2003;75:1740-1745.
10. Marty FM, Rubin RH. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy. Transpl Int. 2006; 19:2-11.
11. Foster PF, Sankary HN, Hart M, et al. Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation. 1989;47:72-74.
12. Nagral A, Ben-Ari Z, Dhillon AP, et al. Eosinophils after acute cellular rejection in liver allografts. Liver Transpl Surg. 1998;4:355-362.
13. Barnes EJ, Abdel-Rehim MM, Goulis Y, et al. Applications and limitations of blood eosinophilia for the diagnosis of acute cellular rejection in liver transplantation. Am J Transplant. 2004;3:432-438.
14. Chatzipetrou MA, Tsaroncha AK, Weppler D, et al. Thrombocytopenia after liver transplantation. Transplantation. 1999;67:702-706.
15. Chang FY, Singh N, Gayowski T, et al. Thombocytopenia in liver transplant recipients. Transplantation. 2000;69:70-75.
16. Demetris AJ, Batts KP, Dhillon AP, et al. Banff schema for grading liver allograft rejection: an international consensus document. J Hepatol. 1997;25:658-663.
17. International panel. Update of the international Banff schema for liver allograft rejection: working recommendations for the his- topathologic staging and reporting of chronic rejection. Hepatology. 2000;31:792-799.
18. Ludwig J. Histopathological diagnosis and terminology of chronic hepatitis. J Hepatol. 1995;23:49 -53.
19. Burra P, De Bona M. Quality of life following organ transplantation. Transpl Int. 2007;20:397-409.
20. Sinclair NR; for the Canadian Multicentre Transplant Study Group. Low-dose steroid therapy in cyclosporine treated renal transplant recipients with well-functioning graft. CMAJ. 1992;147:645-657.
21. Neuberger J, Adams DH. What is the significance of acute liver allograft rejection? J Hepatol. 1998;29:143-150.
22. Padbury RTA, Gunson BK, Dousset B, et al. Steroid withdrawal from long-term immunosuppression in liver allograft recipients. Transplantation. 1993;55:789-794.
23. Lerut J, Ciccarelli O, Mauel E, et al. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based im- munosuppression-5 year results of a prospective study. Transpl Int. 2001;14:420-428.
24. Greig P, Lilly L, Scudamore C, et al. Early steroid withdrawal after liver transplantation: the Canadian Tacrolimus versus microemulsion cyclosporin a trial: 1-year follow-up. Liver Transpl. 2003;9:587-595.
25. Pageaux GP, Calmus Y, Boillot O, et al. Steroid withdrawal at day 14 after liver transplantation: a double-blind, placebo-controlled study. Liver Transpl. 2004;10:1454-1460.
26. Sellers MT, McGuire BM, Haustein SV, et al. Two-dose Daclizumab induction therapy in 209 liver transplants: a single-center analysis source. Transplantation. 2004;78:1212-1217.
27. Ramirez CB, Doria C, di Francesco F, et al. Antil-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months. J Surg Res. 2007;138:198-204.
28. Moench C, Barreiros AP, Schuchmann M, et al. Tacrolimus mono- therapy without steroids after liver transplantation. A prospective randomized double-blinded placebo-controlled trial. Am J Transpl. 2007; 7:1616 -1623.
29. Vo Thi Diem H, Sokal E, Janssen M, et al. Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients. Transplantation. 2003;75:1664-1670.
30. Almawi WY, Hess DA, Chudzik DM, et al. Pretreatment with glucocor- ticoids enhances T-cell effector function: possible implication for immune rebound accompanying glucocorticoid withdrawal. Cell Transplant. 1999;8:637-647.
31. Hricik DE, O'Toole M, Schulak JA, et al. Steroid-free, cyclosporinebased immunosuppression after renal transplantation: a meta analysis of controlled trial. J Am Soc Nephrol. 1993;4:1300-1305.
32. Conti F, Dousset B, Archambeau D, et al. Enhanced risk of steroid- resistant acute rejection following pretransplant steroid therapy in liver graft recipients. Transplantation. 1995;60:1104 -1108.
33. Tisone G, Angelico M, Palmieri G, et al. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation. 1999;67:1308 -1313.
34. Rolles K, Davidson BR, Burroughs AK. A pilot study of immunosup-pressive monotherapy in liver transplantation: tacrolimus versus micro- emulsified cyclosporin. Transplantation. 1999;68:1195-1198.
35. Eason JD, Nair S, Cohen AJ, et al. Steroid-free liver transplantation using rabbit antithymocyte globulin induction and early tacrolimus monotherapy. Transplantation. 2003;75:1396 -1399.
36. Reding R, Gras J, Sokal E, et al. Steroid-free liver transplantation in children. Lancet. 2003;362:2068 -2070.
37. Margarit C, Bilbao I, Castells L, et al. A prospective randomised trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C. Transpl Int. 2005;18:1336 -1345.
38. Liu LC, Fan ST, Lo CM, et al. Interleukin-2 receptor antibody (Basil- iximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of Tacrolimus dosage. Liver Transpl. 2004;10:728 -733.
39. Filipponi F, Callea F, Salizzoni M, et al. Double-blind comparison of hepatitis C histological recurrence rate in HCV + liver transplant recipients fiven Basiliximab + steroids or Basiliximab + placebo, in addition to Cyclosporine and Azathioprine. Transplantation. 2004;78: 1488-1495.
40. Marcos A, Eghtesad B, Fung JJ, et al. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation. 2004;78: 966-971.
41. Marubashi S, Dono K, Amano K, et al. Steroid-free living-donor liver transplantation in adults. Transplantation. 2005;80:704 -706.
42. Boillot O, Mayer DA, Boudjema K, et al. Corticosteroid-free immuno- suppression with tacrolimus following induction with daclizumab: a large randomised clinical study. Liver Transpl. 2005;11:61-67.
43. De Ruvo N, Cucchetti A, Lauro A, et al. Preliminary results of a "Prope" tolerogenic regimen with thymoglobulin pre-treatment and hepatitis C virus recurrence in liver transplantation. Transplantation. 2005;80:8-12.
44. Figueras J, Prieto M, Bernardos A, et al. Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts. Transpl Int. 2006;19:641-648.
45. Llado L, Xiol X, Figueras J, et al. Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomised study. J Hepatol. 2006;44:710-716.
46. Samonakis DN, Mela M, Quaglia A, et al. Rejection rate in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. Transpl Infect Dis. 2006;81:3-12.
47. Chau TN, Quaglia A, Rolles K, et al. Histological patterns of rejection using oral microemulsified cyclosporin and tacrolimus as monotherapy induction after orthotopic liver transplantation. Liver. 2001;21:329 -334.
48. Tzakis AG, Kato T, Nishida S, et al. Preliminary experience with Campath 1H in intestinal and liver transplantation. Transplantation. 2003;75:1227-1231.
49. Hubscher SG, Adams DH, Buckels JA, et al. Massive hemorrhagic necrosis of the liver after liver transplantation. J Clin Pathol. 1989;42: 360 -370.
50. Memon MA, Karademir S, Shen J, et al. Seventh day syndrome-acute hepatocyte apoptosis associated with a unique syndrome of graft loss following liver transplantation. Liver. 2001;21:13-17.
51. Seehofer D, Rayes N, Tullius StG, et al. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Liver Transpl. 2002;8:1138-1146.
52. O'Grady JG, Burroughs A, Hardy P, et al. Tacrolimus versus micro- emulsified cyclosporin in liver transplantation: the TMC randomised controlled trial. Lancet. 2002;360:1119-1125.
53. McAlister VC, Haddad E, Renouf E, et al. Cyclosporin versus Tacrolimus as primary immunousuppressant after liver transplantation: a meta- analysis. Am J Transpl. 2006;6:1578-1585.
54. Golshayan D, Buhler L, Lechler RI, et al. From current immunosup- pressive strategies to clinical tolerance of allografts. Transpl Int. 2007; 20:12-24.
55. Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transpl. 2006;6:1774-1780.